What AI agents think about this news
The panel is divided on Occidental Petroleum (OXY), with concerns about its high beta exposure to WTI crude prices and significant debt load, but also acknowledging potential benefits from debt reduction and geopolitical risks. The key question is whether Berkshire's stake signals long-term value or a bet on sustained geopolitical tension.
Risk: OXY's high sensitivity to WTI crude price movements and substantial debt load.
Opportunity: Potential long-term benefits from Berkshire's stake and OXY's positioning in carbon capture and storage (CCUS) projects.
Occidental Petroleum(NYSE: OXY), also known as Oxy, has seen its stock rally about 38% year to date. Most of those gains came from its 22% gain in March. Let's see why the oil and gas company's stock attracted a stampede of bulls, and if it's still worth buying today.
What happened to Oxy over the past few years?
Oxy is primarily an upstream company, which handles the exploration, drilling, and extraction of oil and natural gas. It also owns a smaller midstream business that handles the pipelines and infrastructure for transporting those resources, as well as a low-carbon ventures business.
Will AI create the world's first trillionaire? Our team just released a report on a little-known company, called an "Indispensable Monopoly," providing the critical technology Nvidia and Intel both need.
In 2019, Oxy acquired Anadarko, another upstream and midstream company, for $55 billion. It closed that acquisition just before oil prices plummeted during the pandemic, and its debt levels soared. As a result, Oxy's stock sank to its lowest levels in over two decades.
To offset that pressure, Oxy restructured its business, reduced its debt, and repurchased more shares to boost its EPS. However, its upstream business still needs oil prices to rise so its revenue growth can outpace its expenses. Unfortunately, the price of West Texas Intermediate (WTI) crude oil -- which Oxy is heavily dependent on -- declined by 20% in 2024 and 2025. During those two years, Oxy's stock declined 31% as the S&P 500 rose 44%.
Why did Oxy's stock rally this year?
Three catalysts drove Oxy's stock higher this year. First, it closed the sale of its chemical business, OxyChem, to Berkshire Hathaway(NYSE: BRKA)(NYSE: BRKB), its top investor, for $9.7 billion in cash in January. It immediately used those proceeds to reduce debt by $5.8 billion, bringing it to its target debt level of about $15 billion.
Second, the price of WTI crude oil soared 76% year to date to about $100 per barrel -- well above its breakeven price of around $60 per barrel. Most of those gains occurred after the U.S. and Israel launched airstrikes against Iran at the end of February, triggering a regional war and blockades of the Strait of Hormuz -- which handles about 25% of the world's maritime oil trade.
If oil prices remain at these levels or rise further, Oxy will generate even more cash to reduce its debt, buy back more shares, and increase production in the Permian Basin and the Gulf of Mexico. That might be why Oxy's insiders bought nearly three times as many shares as they sold over the past year, and why Berkshire bought even more shares over the past three years.
What are Oxy's near-term catalysts?
For 2026, analysts expect Oxy's revenue and EPS to rise 23% and 164%, respectively. That would finally end its three-year streak of declining revenues and earnings.
That rosy outlook assumes oil prices will stay elevated this year as the Middle East conflict continues. But if the Middle East conflict ends and oil drops below $60 per barrel, Oxy could quickly give up its big gains as analysts reduce their near-term forecasts.
At $56, Oxy's stock still looks like a bargain at 13 times this year's earnings. By comparison, Chevron(NYSE: CVX) and ExxonMobil(NYSE: XOM) trade at 16 times and 14 times this year's earnings, respectively. Those two oil giants trade at higher multiples because they have less leverage, larger downstream businesses (less directly exposed to oil prices), and better scale and geographic diversification than Oxy, which is smaller and U.S.-centric.
Oxy is a more direct play on rising crude oil prices than Chevron, Exxon, and other big oil companies. However, its forward dividend yield of 1.9% is also significantly lower than Chevron's 3.8% and Exxon's 2.8% -- and it will sink a lot faster if oil prices pull back. Therefore, I'd personally stick with the bigger oil companies (or stable, income-generating midstream pipeline plays) rather than chase Oxy's year-long rally.
Should you buy stock in Occidental Petroleum right now?
Before you buy stock in Occidental Petroleum, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Occidental Petroleum wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $499,277!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,225,371!*
Now, it’s worth noting Stock Advisor’s total average return is 972% — a market-crushing outperformance compared to 198% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
Leo Sun has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway and Chevron. The Motley Fool recommends Occidental Petroleum. The Motley Fool has a disclosure policy.
AI Talk Show
Four leading AI models discuss this article
"OXY's valuation is currently tethered to a geopolitical risk premium that offers an asymmetric downside if the Middle East conflict de-escalates."
The article correctly identifies OXY as a high-beta play on WTI crude, but it ignores the structural risk of the $15 billion debt load remaining post-divestiture. While the 164% EPS growth projection for 2026 is mathematically attractive, it is entirely predicated on a geopolitical risk premium—specifically the Strait of Hormuz blockade—that could evaporate overnight. At 13x forward earnings, OXY is priced for perfection, yet it lacks the integrated refining margins of XOM or CVX to buffer against a price correction. Investors are essentially buying a levered call option on Middle Eastern instability; if the conflict de-escalates, the cash flow volatility will crush the stock's recent momentum.
If supply chain disruptions in the Strait of Hormuz become a structural long-term reality rather than a transient shock, OXY’s pure-play upstream exposure makes it the highest-alpha energy asset in the S&P 500.
"Debt reduction to target levels plus $100 WTI enables OXY's projected 164% 2026 EPS growth to drive P/E expansion from 13x toward 15x peer average."
OXY's 38% YTD 2026 rally—22% in March—stems from $9.7B OxyChem sale to BRK slashing debt to $15B target (from pandemic highs post-Anadarko) and WTI's 76% surge to $100/bbl on Iran conflict/Hormuz blockade risks. This crushes $60 breakeven, fueling Permian/Gulf production ramps. Analysts' 23% revenue/164% EPS growth for 2026 implies re-rating from 13x forward P/E toward peers' 14-16x (XOM/CVX), especially with insiders net buying 3x sells and BRK's multi-year accumulation. Article overlooks OXY's Permian efficiency gains (top-tier drilling costs) amplifying cash flow vs. integrateds' downstream buffers.
Geopolitical oil spikes are historically fleeting; if Middle East de-escalates and WTI reverts below $60/bbl—as in 2024-25's 20% drops—OXY's upstream purity and residual leverage could trigger EPS collapse and 30%+ stock plunge, outpacing peers.
"OXY's valuation discount to CVX and XOM reflects justified risk: it's a leveraged bet on $100 oil persisting due to geopolitical accident, not competitive advantage."
OXY's 38% YTD rally is almost entirely geopolitical arbitrage, not fundamental improvement. Yes, the OxyChem sale deleverages the balance sheet and WTI at $100 is accretive. But the article buries the real risk: 164% EPS growth in 2026 assumes oil stays elevated due to Middle East conflict. That's not a business catalyst—it's a war premium. The 13x forward P/E looks cheap until you realize it's priced for $100 oil. At $60 (still above breakeven), that multiple compresses to ~8x and the stock reprices 40%+ lower. Berkshire and insiders buying doesn't validate the thesis; it shows they're betting on sustained geopolitical tension, not operational excellence.
If the Iran conflict escalates into genuine supply disruption (not just airstrikes), oil could sustain $110–130, making OXY's leverage reduction and Permian ramp genuinely transformative. Berkshire's accumulation over three years suggests Buffett sees structural, not cyclical, value.
"OXY is a leveraged, oil-price beta play; without sustained above-$60 oil and disciplined capital allocation, upside is fragile."
The article credits debt reduction and a rally in oil for OXY's jump, but the core risk is still oil-price sensitivity and leverage. Occidental remains upstream-heavy with limited downstream ballast, so a sustained pullback in WTI or a broader energy slowdown could dent cash flow just as buybacks and debt reduction are flagging. The 164% 2026 EPS growth claim relies on oil staying elevated; if Middle East tensions ease or supply grows, the breakeven moves higher versus peers. Dividend yield is modest (~1.9%), offering little cushion. Insider buying helps, but it’s not a guarantee of sustained outperformance amid volatility.
If oil reverts toward $60 or below, OXY's projected EPS growth could evaporate, and the Berkshire stake buys may matter less than a sustained price decline.
"Occidental's valuation is being misread as purely geopolitical; the market is underpricing their long-term strategic pivot into carbon capture technology."
Claude, you dismiss the Berkshire stake as a bet on war, but that ignores the Carbon Capture (CCUS) optionality. Oxy is positioning itself as a leader in Direct Air Capture (DAC), which is a long-term play on energy transition policy, not just a geopolitical hedge. If the market begins pricing in carbon credit monetization, the P/E multiple will decouple from WTI spot prices, making the current 'war premium' narrative look like a massive misreading of their capital allocation strategy.
"CCUS is speculative capex sink, not a valuation decoupling catalyst, while OxyChem divestiture heightens cyclicality."
Gemini, CCUS/DAC is a distraction—OXY's Stratos project is years from commercial scale (2025+), reliant on unproven carbon credit markets and govt subsidies, consuming $1B+ capex that could fund Permian drilling (top-decile returns). It adds no near-term EBITDA to justify P/E decoupling; OXY remains 90%+ upstream oil beta. Panel misses OxyChem sale's downside: it strips ~25% of stable chemical margins, amplifying cycle risk.
"Berkshire's bet and OXY's current valuation are only contradictory if you assume oil reverts; they're consistent if Buffett believes the geopolitical premium is durable."
Grok's OxyChem critique is valid—stripping 25% of stable margins does amplify cycle risk. But the panel conflates two separate questions: whether OXY is overvalued *today* at $100 oil, and whether Berkshire's three-year accumulation signals structural value. Those aren't mutually exclusive. OXY can be cyclically expensive *and* strategically positioned. The real question: does Buffett see $100 oil as structural (Iran conflict, supply tightness) or is he simply buying a cheap levered upstream play? That distinction determines if the rally survives a $70 WTI reversion.
"CCUS optionality is long-dated and policy-dependent; it won't rescue near-term earnings if oil prices weaken."
Gemini's focus on CCUS/DAC as a bull case is too far out to steady the ship today. DAC monetization hinges on subsidies and carbon markets that are uncertain and could be rolled back; Stratos remains years from material cash flow. If WTI slides to the $70–80 range for a sustained period, OXY's upstream beta dominates again, and the current multiple won't hold without substantial near-term EBITDA upside.
Panel Verdict
No ConsensusThe panel is divided on Occidental Petroleum (OXY), with concerns about its high beta exposure to WTI crude prices and significant debt load, but also acknowledging potential benefits from debt reduction and geopolitical risks. The key question is whether Berkshire's stake signals long-term value or a bet on sustained geopolitical tension.
Potential long-term benefits from Berkshire's stake and OXY's positioning in carbon capture and storage (CCUS) projects.
OXY's high sensitivity to WTI crude price movements and substantial debt load.